PACKAGE LEAFLET: INFORMATION FOR THE USER Metoclopramide Hydrochloride 10 mg tablets (Metoclopramide Hydrochloride)

Similar documents
Package leaflet: Information for the user. Tetrabenazine 25 mg tablets. tetrabenazine

1. What Betahistine dihydrochloride tablets is and what it is used for

Package leaflet: Information for the user

Package Leaflet: Information for the User. Kemadrin tablets 5 mg procyclidine hydrochloride

Package Leaflet: Information for the user Kemadrin 5 mg Tablets Procyclidine hydrochloride

Package leaflet: Information for the user. Tardiben 25 mg tablets. Tetrabenazine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tetmodis 25 mg tablets

Package Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate)

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

Package leaflet: Information for the user. Levonorgestrel 1.5 mg Tablet. levonorgestrel

Package leaflet: Information for the user

Package Leaflet: Information for the user. Methocarbamol 750mg Film-Coated Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

If you have any questions about how Letrozole Tablets works or why this medicine has been prescribed for you, ask your doctor.

PACKAGE LEAFLET. Page 1 of 6

Package leaflet: Information for the patient

Sibelium 5 mg Tablets flunarizine

1. What Miacalcic is and what it is used for

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

PACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin Sandoz 5 mg, prolonged-release tablets. Alfuzosin hydrochloride

Package leaflet: Information for the patient. Sycrest 5 mg sublingual tablets Sycrest 10 mg sublingual tablets asenapine

Package leaflet: Information for the user. Tianeptine 12.5 mg Film Coated Tablets (Tianeptine Sodium)

PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)

Tiorfan Hidrasec Tiorfix Tiorfast 100 mg PACKAGE LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER. TERAZOSIN 2 mg TABLETS TERAZOSIN 5 mg TABLETS. Terazosin

Aciclovir Apotex 800 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 800 mg tabletten Aciclovir

Package leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone

Package leaflet: Information for the user. Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user

Aciclovir Apotex 200 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

PACKAGE LEAFLET: INFORMATION FOR THE USER ANQUIL 0.25mg TABLETS Benperidol

TREANA 5mg and 10mg Film-coated Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Ondansetron BMM Pharma 8 mg film-coated tablets. Ondansetron

Package leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid

PACKAGE LEAFLET. Page 1 of 8

PACKAGE LEAFLET: INFORMATION FOR THE USER

It is used to treat the symptoms of dementia in people diagnosed as having mild to moderately severe Alzheimer s disease.

PACKAGE LEAFLET: INFORMATION FOR THE USER

PATIENT INFORMATION LEAFLET. PACKAGE LEAFLET: INFORMATION FOR THE USER Artin 75 mg tablets Artin 150 mg tablets Artin 300 mg tablets.

Package leaflet: information for the user

Package leaflet: Information for the patient. Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets.

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan

PATIENT INFORMATION LEAFLET ZOXADON TABLETS RANGE

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Bluefish 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride

Package leaflet: Information for the user Arlevert 20 mg/40 mg tablets cinnarizine/dimenhydrinate

PACKAGE LEAFLET: INFORMATION FOR THE USER. BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE

PACKAGE LEAFLET: INFORMATION FOR THE USER Meronem IV 500 mg and 1 g Powder for solution for injection or infusion meropenem

Package leaflet: information for the user. Valaciclovir Bluefish 500 mg Film-Coated Tablets Valaciclovir

Package Leaflet: Information for the User Zotron 4mg/2ml (ή 8mg/4ml) Solution for Injection or Infusion ondansetron

Package leaflet: Information for the patient. Forxiga 5 mg film-coated tablets Forxiga 10 mg film-coated tablets dapagliflozin

Package leaflet: Information for the patient. Flynise 5 mg Orodispersible Tablets desloratadine

Package Leaflet: Information for the User

Consumer Medicine Information

Package leaflet: Information for the patient

Package leaflet: Information for the user NON DROWSY SUDAFED. DECONGESTANT 60 mg FILM-COATED TABLETS Pseudoephedrine hydrochloride

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

Package leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Zolmitriptan Teva 5 mg film-coated tablets. Zolmitriptan

Package leaflet: Information for the user. Lorastad 10 mg Tablets loratadine

Package leaflet: Information for the user. Aripiprazole Universal Farma 15 mg tablets. Aripiprazole Universal Farma 10 mg tablets

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

Package leaflet: Information for the user. ARICEPT 10 mg Film Coated Tablets (Donepezil Hydrochloride)

What is in this leaflet

Package leaflet: Information for the user. GLUCOPHAGE 500 mg powder for oral solution in sachets metformin hydrochloride

Package leaflet: Information for the user. Zomig 2.5 mg tablets zolmitriptan

Package leaflet: Information for the user. GlucaGen HypoKit 1 mg Powder and solvent for solution for injection Glucagon

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan

Motens 2 mg and 4 mg Tablets lacidipine

2 What you need to know before you take Zantac

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. NEFOXEF 120 MG FILM-COATED TABLETS NEFOXEF 180 MG FILM-COATED TABLETS Fexofenadine hydrochloride

Package leaflet: Information for the user. Sumatriptan Amneal 100 mg tablets. sumatriptan

Package leaflet: Information for the user. Ondansetron 4mg/5ml Syrup (ondansetron as ondansetron hydrochloride dihydrate)

Package leaflet: Information for the user. Aripiprazole Accord 15 mg tablets Aripiprazole Accord 30 mg tablets. aripiprazole

PACKAGE LEAFLET: INFORMATION FOR THE USER. Anastrozole 1 mg film-coated tablets

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

1 What Zofran Suppositories are and what they are used for

1. What Donepezil Hydrochloride is and what it is used for

ReQuip 0.25 mg, 1 mg, 2 mg, 5 mg film-coated tablets ropinirole (as the hydrochloride)

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Package leaflet: Information for the user. Cyclizine Lactate 50 mg/ml Injection

Package leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER Metoclopramide Hydrochloride 10 mg tablets (Metoclopramide Hydrochloride) Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What Metoclopramide Hydrochloride tablets is and what it is used for 2. What you need to know before you take Metoclopramide Hydrochloride tablets 3. How to take Metoclopramide Hydrochloride tablets 4. Possible side effects 5. How to store Metoclopramide Hydrochloride tablets 6. Contents of the pack and other information 1. What Metoclopramide Hydrochloride tablets is and what it is used for Metoclopramide Hydrochlride is an antiemetic. It contains a medicine called metoclopramide. It works on a part of your brain that prevents you from feeling sick (nausea) or being sick (vomiting). Adult population: Metoclopramide Hydrochloride is used in adults: to prevent delayed nausea and vomiting that may occur after chemotherapy to prevent nausea and vomiting caused by radiotherapy to treat nausea and vomiting including nausea and vomiting which may occur with a migraine. Metoclopramide can be taken with oral painkillers in case of migraine to help painkillers work more effectively. Paediatric population Metoclopramide Hydrochloride is indicated in children (aged 1-18 years) if other treatment does not work or cannot be used to prevent delayed nausea and vomiting that may occur after chemotherapy 2. What you need to know before you take Metoclopramide Hydrochloride tablets Do not take Metoclopramide Hydrochloride tablets: if you are allergic (hypersensitive) to metoclopramide or any of the other ingredients of this medicine (listed in section 6) if you have bleeding, obstruction or a tear in your stomach or gut. if you have or may have a rare tumour of the adrenal gland, which sits near the kidney (pheochromocytoma). if you have ever had involuntary muscle spasms (tardive dyskinesia), when you have been treated with a medicine. if you have epilepsy

if you have Parkinson s disease if you are taking levodopa (a medicine for Parkinson s disease) or dopaminergic agonists (see below Other medicines and Metoclopramide Hydrochloride tablets ) if you have ever had an abnormal blood pigment levels (methaemoglobinemia) or NADH cytochrome-b5 deficiency Do not give Metoclopramide Hydrochloride tablets to a child less than 1 year of age (see below Children and adolescents ). Warnings and precautions Talk to your doctor, pharmacist or nurse before taking Metoclopramide Hydrochloride tablets if: you have a history of abnormal heart beats (QT interval prolongation) or any other heart problems you have problems with the levels of salts in your blood, such as potassium, sodium and magnesium. you are using other medicines known to affect the way your heart beats you have any neurological (brain) problems you have liver or kidney problems. The dose may be reduced (see section 3). Your doctor may perform blood tests to check your blood pigment levels. In cases of abnormal levels (methaemoglobinemia), the treatment should be immediately and permanently stopped. You must wait at least 6 hours between each metoclopramide dose, even in case of vomiting and rejection of the dose, in order to avoid overdose. Children and adolescents Uncontrollable movements (extrapyramidal disorders) may occur in children and young adults. This medicine must not be used in children below 1 year of age because of the increased risk of the uncontrollable movements (see above Do not take Metoclopramide Hydrochloride tablets if ). Other medicines and Metoclopramide Hydrochloride tablets Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines. This is because some medicines can affect the way Metoclopramide Hydrochloride tablets works or Metoclopramide Hydrochloride tablets can affect how other medicines work. These medicines include the following: - levodopa or other medicines used to treat Parkinson s disease (see above Do not take Metoclopramide Hydrochloride tablets if ) - anticholinergics (medicines used to relieve stomach cramps or spasms) - morphine derivatives (medicines used to treat severe pain) - sedative medicines - any medicines used to treat mental health problems - digoxin (medicine used to treat heart failure) - cyclosporine (medicine used to treat certain problems with the immune system) - mivacurium and suxamethonium (medicines used to relax muscles) - fluoxetine and paroxetine (medicine used to treat depression) Metoclopramide Hydrochloride tablets with alcohol Alcohol should not be consumed during treatment with metoclopramide because it increases the sedative effect of Metoclopramide Hydrochloride tablets.

Pregnancy, breast-feeding and fertility If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before being given this medicine. If necessary, Metoclopramide Hydrochloride tablets may be taken during pregnancy. Your doctor will decide whether or not you should be given this medicine. Trade Metoclopramide Hydrochloride tablets name is not recommended if you are breast-feeding because metoclopramide passes into breast milk and may affect your baby. Driving and using machines You may feel drowsy, dizzy or have uncontrollable twitching, jerking or writhing movements and unusual muscle tone causing distortion of the body after taking Metoclopramide Hydrochloride tablets. This may affect your vision and also interfere with your ability to drive and use machines. Metoclopramide Hydrochloride tablets contains Lactose This drug contains lactose monohydrate. Patients with rare hereditary abnormalities of galactose tolerance, those with Lapp lactase deficiency or glucose-galactose malabsorption should not use this medication. Tell your doctor if you know you have a sugar intolerance. 3. How to take Metoclopramide Hydrochloride tablets Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Adult population: The recommended single dose is 10 mg, repeated up to three times daily. The maximum recommended dose per day is 30 mg or 0.5 mg/kg body weight. The maximum recommended treatment duration is 5 days. To prevent delayed nausea and vomiting that may occur after chemotherapy (children aged 1-18 years) The recommended dose is 0.1 to 0.15 mg/kg body weight, repeated up to 3 times daily, taken by Mouth. The maximum dose in 24 hours is 0.5 mg/kg body weight. Dosing table Age Body Weight Dose Frequency 1-3 years 10-14 kg 1 mg Up to 3 times daily 3-5 years 15-19 kg 2 mg Up to 3 times daily 5-9 years 20-29 kg 2.5 mg Up to 3 times daily 9-18 years 30-60 kg 5 mg Up to 3 times daily 15-18 years Over 60kg 10 mg Up to 3 times daily Device / instruction for use You should not take this medicine for more than 5 days to prevent delayed nausea and vomiting that may occur after chemotherapy. Metoclopramide Hydrochloride tablets is not suitable for use in children weighing less than 30 kg. Other pharmaceutical forms/strengths may be more appropriate for administration

Method of administration Swallow the tablet with glass of water. You must wait at least 6 hours between each metoclopramide dose, even in case of vomiting and rejection of the dose, in order to avoid overdose. Older people The dose may need to be reduced depending on kidney problems, liver problems and overall health. Adults with kidney problems Talk to your doctor if you have kidney problems. The dose should be reduced if you have moderate or severe kidney problems. Adults with liver problems Talk to your doctor if you have liver problems. The dose should be reduced if you have severe liver problems. Children and adolescents Metoclopramide must not be used in children aged less than 1 year (see section 2). If you take more Metoclopramide Hydrochloride tablets than you should Contact your doctor or pharmacist straight away. You may experience uncontrollable movements (extrapyramidal disorders), feel drowsy, have some troubles of consciousness, be confused, have hallucination and heart problems. You doctor may prescribe you a treatment for these signs if necessary. If you forget to take Metoclopramide Hydrochloride tablets Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist. 4. Possible side effects Like all medicines, Metoclopramide Hydrochloride tablets can cause side effects, although not everybody gets them. Stop the treatment and talk straight away to your doctor, pharmacist or nurse if you experience one of the following signs while having this medicine: - uncontrollable movements (often involving head or neck). These may occur in children or young adults and particularly when high doses are used. These signs usually occur at the beginning of treatment and may even occur after one single administration. These movements will stop when treated appropriately. - high fever, high blood pressure, convulsions, sweating, production of saliva. These may be signs of a condition called neuroleptic malignant syndrome. - Itching or skin rashes, swelling of the face, lips or throat, difficulty in breathing. These may be signs of an allergic reaction, which may be severe. Very common (may affect more than 1 in 10 people) feeling drowsy. Common (may affect up to 1 in 10 people) depression

uncontrollable movements such as tics, shaking, twisting movements or muscle contracture (stiffness, rigidity) symptoms similar to Parkinson disease (rigidity, tremor) feel restless blood pressure decrease (particularly with intravenous route) diarrhoea feeling weak. Uncommon (may affect up to 1 in 100 people) raised levels of a hormone called prolactin in the blood which may cause: milk production in men, and women who are not breast-feeding irregular periods hallucination decreased level of consciousness slow heartbeat (particularly with intravenous route) allergy Rare (may affect up to 1 in 1,000 people) confusional state convulsion (especially in patients with epilepsy). Not known (frequency cannot be estimated from the available data) abnormal blood pigment levels: which may change the colour of your skin abnormal development of breasts (gynaecomastia) involuntary muscle spasms after prolonged use, particularly in elderly patients high fever, high blood pressure, convulsions, sweating, production of saliva. These may be signs of a condition called neuroleptic malignant syndrome changes in heart beat, which may be shown on an ECG test cardiac arrest (particularly with injection route) shock (severe decrease of heart pressure) (particularly with injection route) fainting (particularly with intravenous route) allergic reaction which may be severe (particularly with intravenous route) very high blood pressure. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Metoclopramide Hydrochloride tablets Keep this medicine out of the sight and reach of children. Store below 30 C. Do not use this medicine after the expiry date which is stated on the strips and carton after EXP. The expiry date refers to the last day of that month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines no longeruse. These measures will help to protect the environment.

6. Contents of the pack and other information What Metoclopramide Hydrochloride tablets contains The name of your medicine is Metoclopramide Hydrochloride tablets, and the active substance is metoclopramide hydrochloride. Metoclopramide Hydrochloride tablets contain 10 mg metoclopramide hydrochloride. The tablets contain the following non-active ingredients: Lactose monohydrate, pre-gelatinised starch, maize starch, anhydrous colloidal silica, magnesium stearate. What Metoclopramide Hydrochloride tablets looks like and contents of the pack White to off-white, round, biconvex tablets with the inscription BD on one side and a score line on the other side. The tablet can be divided into equal halves. The tablets are packaged in PVC/PVdC/aluminium blister strips. The carton contains 20, 24, 28, 30, 40, 50, 60, 84, 100, 500 tablets. Marketing Authorisation Holder and Manufacturer Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex HA1 4HF, United Kingdom This medicinal product is authorised in the Member States of the EEA under the following names: Name of the Member State Cyprus Spain Italy The Netherlands Malta United Kingdom Austria Denmark Estonia Finland Ireland Norway Poland Sweden Name of the medicinal product Metoclopramide Accord 10 mg tablety Metoclopramide Accord 10 mg comprimidos Metoclopramide Accord Metoclopramidemonohydrochloride Accord 10 mg Tabletten Metoclopramide10 mg tablets Metoclopramide Hydrochloride 10 mg tablets Metoclopramid hydrochloride Accord 10 mg Tabletten Metoclopramide hydrochloride Accord Metoclopramide Accord Metoclopramide Accord 10 mg tabletti Metoclopramide Hydrochloride 10 mg tablets Metoclopramide Accord Olamide Metoclopramide Accord 10 mg tabletter This leaflet was last approved in 09/2016.